#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	531	14902	16S	1529	1529	99.93	16S.l15.c17.ctg.1	2315	785.5	0	.	n	.	0	C1450T	SNP	1450	1450	C	1818	1818	T	932	T,G,C	928,3,1	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	531	14902	16S	1529	1529	99.93	16S.l15.c17.ctg.1	2315	785.5	1	SNP	n	C1184T	0	.	.	1184	1184	C	1552	1552	C	926	C	926	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	25514	23S	2890	2890	99.9	23S.l15.c4.ctg.1	4008	792.5	0	.	n	.	0	G1337A	SNP	1337	1337	G	1932	1932	A	1022	A,G,C	1019,2,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	25514	23S	2890	2890	99.9	23S.l15.c4.ctg.1	4008	792.5	0	.	n	.	0	C1346T	SNP	1346	1346	C	1941	1941	T	987	T,C,A,G	539,443,3,2	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	25514	23S	2890	2890	99.9	23S.l15.c4.ctg.1	4008	792.5	0	.	n	.	0	T1971C	SNP	1971	1971	T	2566	2566	C	845	C,A	844,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	25514	23S	2890	2890	99.9	23S.l15.c4.ctg.1	4008	792.5	1	SNP	n	A2045G	0	.	.	2045	2045	A	2640	2640	A	792	A,T	791,1	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	25514	23S	2890	2890	99.9	23S.l15.c4.ctg.1	4008	792.5	1	SNP	n	C2597T	0	.	.	2597	2597	C	3192	3192	C	936	C,T	935,1	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	25514	23S	2890	2890	99.9	23S.l15.c4.ctg.1	4008	792.5	0	HET	.	.	.	G996A,T,C	.	996	996	G	1591	1591	G	950	G,A,T,C	499,447,2,2	.	.
folP.WHO_G_01367c	folP.WHO_G_01367c	1	1	27	2254	folP	852	852	99.88	folP.l15.c4.ctg.1	1889	148.1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	5340	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3910	170.1	1	SNP	p	S91F	0	.	.	271	273	TCC	877	879	TCC	210;212;214	T;C,A,T;C	210;210,1,1;214	gyrA.WHO_F_00668c:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	5340	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3910	170.1	1	SNP	p	D95N	0	.	.	283	285	GAC	889	891	GAC	214;218;216	G;A,C;C,T	214;217,1;215,1	gyrA.WHO_F_00668c:1:1:D95N:gyrA.95N:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	5340	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3910	170.1	1	SNP	p	D95G	0	.	.	283	285	GAC	889	891	GAC	214;218;216	G;A,C;C,T	214;217,1;215,1	gyrA.WHO_F_00668c:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
mtrR.WHO_O_01438	mtrR.WHO_O_01438	1	1	539	1890	mtrR	633	633	99.21	mtrR.l15.c4.ctg.1	1900	123.9	0	.	p	.	0	A39T	NONSYN	115	117	GCC	665	667	ACC	222;224;224	A;C;C	222;224;224	.	.
mtrR.WHO_O_01438	mtrR.WHO_O_01438	1	1	539	1890	mtrR	633	633	99.21	mtrR.l15.c4.ctg.1	1900	123.9	0	.	p	.	0	Y105H	NONSYN	313	315	TAC	863	865	CAC	240;240;244	C;A;C	240;240;244	.	.
mtrR.WHO_O_01438	mtrR.WHO_O_01438	1	1	539	1890	mtrR	633	633	99.21	mtrR.l15.c4.ctg.1	1900	123.9	0	.	p	.	0	E117K	NONSYN	349	351	GAA	899	901	AAA	237;238;239	A;A,T;A	237;237,1;239	.	.
mtrR.WHO_O_01438	mtrR.WHO_O_01438	1	1	539	1890	mtrR	633	633	99.21	mtrR.l15.c4.ctg.1	1900	123.9	1	SNP	p	G45D	0	.	.	133	135	GGC	683	685	GGC	223;224;225	G;G;C	223;224;225	mtrR.WHO_O_01438:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	19	1150	mtrR_promoter	250	250	100.0	mtrR_promoter.l15.c4.ctg.1	1505	95.3	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
parC.WHO_F_01444	parC.WHO_F_01444	1	1	539	5112	parC	2304	2304	99.7	parC.l15.c4.ctg.1	3455	184.4	0	.	p	.	0	V384I	NONSYN	1150	1152	GTC	1649	1651	ATC	264;262;260	A,T;T,C;C	263,1;261,1;260	.	.
parC.WHO_F_01444	parC.WHO_F_01444	1	1	539	5112	parC	2304	2304	99.7	parC.l15.c4.ctg.1	3455	184.4	0	.	p	.	0	V435A	NONSYN	1303	1305	GTG	1802	1804	GCA	279;278;279	G,T,A;C;A,T	276,1,1;278;278,1	.	.
parC.WHO_F_01444	parC.WHO_F_01444	1	1	539	5112	parC	2304	2304	99.7	parC.l15.c4.ctg.1	3455	184.4	0	.	p	.	0	V596I	NONSYN	1786	1788	GTT	2285	2287	ATT	241;241;235	A;T;T	241;241;235	.	.
parC.WHO_F_01444	parC.WHO_F_01444	1	1	539	5112	parC	2304	2304	99.7	parC.l15.c4.ctg.1	3455	184.4	1	SNP	p	D86N	0	.	.	256	258	GAC	755	757	GAC	211;213;214	G,C;A,G;C,A	210,1;212,1;213,1	parC.WHO_F_01444:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_F_01444	parC.WHO_F_01444	1	1	539	5112	parC	2304	2304	99.7	parC.l15.c4.ctg.1	3455	184.4	1	SNP	p	S87R	0	.	.	259	261	AGT	758	760	AGT	211;208;206	A,C;G;T,G,C	210,1;208;204,1,1	parC.WHO_F_01444:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_F_01444	parC.WHO_F_01444	1	1	539	5112	parC	2304	2304	99.7	parC.l15.c4.ctg.1	3455	184.4	1	SNP	p	S87I	0	.	.	259	261	AGT	758	760	AGT	211;208;206	A,C;G;T,G,C	210,1;208;204,1,1	parC.WHO_F_01444:1:1:S87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_F_01444	parC.WHO_F_01444	1	1	539	5112	parC	2304	2304	99.7	parC.l15.c4.ctg.1	3455	184.4	1	SNP	p	S87W	0	.	.	259	261	AGT	758	760	AGT	211;208;206	A,C;G;T,G,C	210,1;208;204,1,1	parC.WHO_F_01444:1:1:S87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_F_01444	parC.WHO_F_01444	1	1	539	5112	parC	2304	2304	99.7	parC.l15.c4.ctg.1	3455	184.4	1	SNP	p	S88P	0	.	.	262	264	TCC	761	763	TCC	210;209;209	T;C;C	210;209;209	parC.WHO_F_01444:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	4514	parE	1986	1986	99.9	parE.l15.c4.ctg.1	3065	183.5	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1766	1768	GGC	250;247;245	G,T;G;C	248,2;247;245	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.22.001	penA.22.001	1	1	27	4174	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2870	181.3	1	SNP	p	A311V	0	.	.	931	933	GCA	1461	1463	GCA	242;242;242	G;C,A;A	242;241,1;242	penA.22.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.001	penA.22.001	1	1	27	4174	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2870	181.3	1	SNP	p	I312M	0	.	.	934	936	ATC	1464	1466	ATC	241;241;240	A,C;T,A;C,A	240,1;239,2;239,1	penA.22.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.001	penA.22.001	1	1	27	4174	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2870	181.3	1	SNP	p	V316T	0	.	.	946	948	GTG	1476	1478	GTG	235;236;235	G;T;G	235;236;235	penA.22.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.001	penA.22.001	1	1	27	4174	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2870	181.3	1	SNP	p	V316P	0	.	.	946	948	GTG	1476	1478	GTG	235;236;235	G;T;G	235;236;235	penA.22.001:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.001	penA.22.001	1	1	27	4174	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2870	181.3	1	SNP	p	T484S	0	.	.	1450	1452	ACC	1980	1982	ACC	259;259;256	A,G;C;C,G	258,1;259;255,1	penA.22.001:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.001	penA.22.001	1	1	27	4174	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2870	181.3	1	SNP	p	A502P	0	.	.	1504	1506	GCG	2034	2036	GCG	241;242;242	G;C;G	241;242;242	penA.22.001:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.001	penA.22.001	1	1	27	4174	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2870	181.3	1	SNP	p	A502V	0	.	.	1504	1506	GCG	2034	2036	GCG	241;242;242	G;C;G	241;242;242	penA.22.001:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.001	penA.22.001	1	1	27	4174	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2870	181.3	1	SNP	p	G543S	0	.	.	1627	1629	GGT	2157	2159	GGT	228;231;231	G;G;T	228;231;231	penA.22.001:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.001	penA.22.001	1	1	27	4174	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2870	181.3	1	SNP	p	G546S	0	.	.	1636	1638	GGC	2166	2168	GGC	232;234;233	G;G;C	232;234;233	penA.22.001:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.001	penA.22.001	1	1	27	4174	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2870	181.3	1	SNP	p	P552S	0	.	.	1654	1656	CCG	2184	2186	CCG	252;254;255	C;C;G,T	252;254;254,1	penA.22.001:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_F_00106	ponA.WHO_F_00106	1	1	27	5658	ponA	2397	2397	99.96	ponA.l15.c4.ctg.1	3474	202.8	1	SNP	p	L421P	0	.	.	1261	1263	CTG	1857	1859	CTG	229;232;233	C;T,G;G	229;230,2;233	ponA.WHO_F_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2472	porA	1146	1146	99.83	porA.l15.c4.ctg.1	2332	132.0	0	.	p	.	0	M83fs	FSHIFT	247	247	A	819	819	C	179	C	179	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	304	porB1a	984	297	90.03	porB1a.l6.c30.ctg.1	1012	26.8	0	.	p	.	0	H217N	NONSYN	649	651	CAT	740	742	AAT	4;4;4	A;A;T	4;4;4	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	304	porB1a	984	297	90.03	porB1a.l6.c30.ctg.1	1012	26.8	0	.	p	.	0	D218N	NONSYN	652	654	GAT	743	745	AAT	4;4;4	A;A;T	4;4;4	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	304	porB1a	984	297	90.03	porB1a.l6.c30.ctg.1	1012	26.8	0	.	p	.	0	A222V	NONSYN	664	666	GCT	755	757	GTT	5;5;5	G;T;T	5;5;5	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	304	porB1a	984	297	90.03	porB1a.l6.c30.ctg.1	1012	26.8	0	.	p	.	0	V226A	NONSYN	676	678	GTA	767	769	GCG	3;3;3	G;C;G	3;3;3	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	304	porB1a	984	297	90.03	porB1a.l6.c30.ctg.1	1012	26.8	0	.	p	.	0	.	MULTIPLE	700	702	ACT	790	792	GTA	5;5;5	G;T;A	5;5;5	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	304	porB1a	984	297	90.03	porB1a.l6.c30.ctg.1	1012	26.8	0	.	p	.	0	N237K	NONSYN	709	711	AAC	799	801	AAA	6;6;7	A;A;A	6;6;7	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	304	porB1a	984	297	90.03	porB1a.l6.c30.ctg.1	1012	26.8	0	.	p	.	0	D238fs	FSHIFT	712	712	G	802	802	G	7	G	7	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	2902	porB1b	1047	1047	99.04	porB1b.l15.c17.ctg.1	2124	169.8	0	.	p	.	0	K143Q	NONSYN	427	429	AAA	1129	1131	CAA	214;214;215	C,A;A,G;A,G	213,1;213,1;214,1	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	2902	porB1b	1047	1047	99.04	porB1b.l15.c17.ctg.1	2124	169.8	0	.	p	.	0	E212G	NONSYN	634	636	GAA	1336	1338	GGT	244;246;246	G,T;G,T;T	243,1;245,1;246	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	2902	porB1b	1047	1047	99.04	porB1b.l15.c17.ctg.1	2124	169.8	0	.	p	.	0	H213D	NONSYN	637	639	CAT	1339	1341	GAT	243;243;244	G,A;A;T,G	242,1;243;243,1	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	2902	porB1b	1047	1047	99.04	porB1b.l15.c17.ctg.1	2124	169.8	0	.	p	.	0	V215A	NONSYN	643	645	GTT	1345	1347	GCT	251;250;251	G;C;T	251;250;251	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	2902	porB1b	1047	1047	99.04	porB1b.l15.c17.ctg.1	2124	169.8	0	.	p	.	0	I218M	NONSYN	652	654	ATC	1354	1356	ATG	239;240;240	A;T;G	239;240;240	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	2902	porB1b	1047	1047	99.04	porB1b.l15.c17.ctg.1	2124	169.8	0	.	p	.	0	R257K	NONSYN	769	771	AGG	1471	1473	AAG	225;227;226	A;A;G	224;226;226	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	2902	porB1b	1047	1047	99.04	porB1b.l15.c17.ctg.1	2124	169.8	1	SNP	p	G120K	0	.	.	358	360	GGC	1060	1062	GGC	264;263;259	G;G,A;C	264;262,1;259	porB1b.WHO_P_02204c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_F_02153c	rpoB.WHO_F_02153c	1	1	27	10256	rpoB	4179	4179	99.98	rpoB.l15.c4.ctg.1	5371	238.0	1	SNP	p	H553N	0	.	.	1657	1659	CAT	2291	2293	CAT	285;282;284	C;A;T,A	285;282;283,1	rpoB.WHO_F_02153c:1:1:H553N:rpoB.553N:H552N. High-level resistance to Rifampicin	.
rpsJ.WHO_F_02142c	rpsJ.WHO_F_02142c	1	1	27	1516	rpsJ	312	312	100.0	rpsJ.l6.c4.ctg.1	1272	147.5	1	SNP	p	V57M	0	.	.	169	171	GTG	648	650	GTG	289;291;288	G;T;G	289;291;288	rpsJ.WHO_F_02142c:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
